From the Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Department of Radiology, Jin Yin-Tan Hospital, Wuhan, China.
Invest Radiol. 2020 Jun;55(6):332-339. doi: 10.1097/RLI.0000000000000674.
In late December 2019, an outbreak of coronavirus disease (COVID-19) in Wuhan, China was caused by a novel coronavirus, newly named severe acute respiratory syndrome coronavirus 2. We aimed to quantify the severity of COVID-19 infection on high-resolution chest computed tomography (CT) and to determine its relationship with clinical parameters.
From January 11, 2020, to February 5, 2020, the clinical, laboratory, and high-resolution CT features of 42 patients (26-75 years, 25 males) with COVID-19 were analyzed. The initial and follow-up CT, obtained a mean of 4.5 days and 11.6 days from the illness onset were retrospectively assessed for the severity and progression of pneumonia. Correlations among clinical parameters, initial CT features, and progression of opacifications were evaluated with Spearman correlation and linear regression analysis.
Thirty-five patients (83%) exhibited a progressive process according to CT features during the early stage from onset. Follow-up CT findings showed progressive opacifications, consolidation, interstitial thickening, fibrous strips, and air bronchograms, compared with initial CT (all P < 0.05). Before regular treatments, there was a moderate correlation between the days from onset and sum score of opacifications (R = 0.68, P < 0.01). The C-reactive protein, erythrocyte sedimentation rate, and lactate dehydrogenase showed significantly positive correlation with the severity of pneumonia assessed on initial CT (Rrange, 0.36-0.75; P < 0.05). The highest temperature and the severity of opacifications assessed on initial CT were significantly related to the progression of opacifications on follow-up CT (P = 0.001-0.04).
Patients with the COVID-19 infection usually presented with typical ground glass opacities and other CT features, which showed significant correlations with some clinical and laboratory measurements. Follow-up CT images often demonstrated progressions during the early stage from illness onset.
2019 年 12 月下旬,中国武汉发生了一种新型冠状病毒引发的冠状病毒病(COVID-19)疫情。这种新型冠状病毒被新命名为严重急性呼吸综合征冠状病毒 2。我们旨在通过高分辨率胸部计算机断层扫描(CT)量化 COVID-19 感染的严重程度,并确定其与临床参数的关系。
从 2020 年 1 月 11 日至 2 月 5 日,分析了 42 名(26-75 岁,25 名男性)COVID-19 患者的临床、实验室和高分辨率 CT 特征。回顾性评估初始和随访 CT,从发病到发病的平均时间分别为 4.5 天和 11.6 天,以评估肺炎的严重程度和进展。使用 Spearman 相关和线性回归分析评估临床参数、初始 CT 特征与混浊进展之间的相关性。
根据发病早期的 CT 特征,35 例(83%)患者表现出进行性过程。与初始 CT 相比,随访 CT 发现混浊、实变、间质增厚、纤维带和空气支气管征呈进行性进展(均 P <0.05)。在常规治疗之前,从发病到混浊评分之和的天数有中度相关性(R = 0.68,P <0.01)。C 反应蛋白、红细胞沉降率和乳酸脱氢酶与初始 CT 评估的肺炎严重程度呈显著正相关(R 范围,0.36-0.75;P <0.05)。初始 CT 上的最高体温和混浊程度与随访 CT 上的混浊进展显著相关(P = 0.001-0.04)。
COVID-19 感染患者通常表现出典型的磨玻璃混浊和其他 CT 特征,这些特征与一些临床和实验室测量有显著相关性。在发病早期,随访 CT 图像通常显示进展。